조혈모세포이식 후 중환자실 치료를 받은 소아 환자의 예후 예견 인자 분석
Prediction of Prognosis for Children Cared in Intensive Care Unit (ICU) after Hematopoietic Stem Cell Transplantation (HSCT)
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Pediatric Index of Mortality 2 (PIM2) is a useful scoring system for the prediction of prognosis, and Oncological Pediatric Risk of Mortality (O-PRISM) for ICU support in children with HSCT. We investigated prognostic prediction and risk factors for survival through early detection of admission to ICU after HSCT. Methods: We reviewed retrospectively medical records of children cared for in ICU after HSCT between 2004 and 2010. Patients who died within 2 hours after admittance to ICU were excluded. We analyzed the worst parameters in ICU by a t-test, Cox-regression, multiple logistic regression and a receiver operating characteristics curve (ROC). Results: 54 children, with fifty-five disease events, were admitted to ICU after HSCT. Sixteen children were diagnosed with high-risk disease status and 8 with non-malignant diseases. Stem cells were sourced from 14 matched siblings, 22 unrelated donors and 19 cord bloods. The median duration in ICU was 8.5 days (0.5−110). The reasons for admission to ICU were 32 pulmonary, 14 neurologic, and 9 hemodynamic events. Six patients (11.1%) survived after intensive care. The factor indicating discharge with survival was mental status (p = 0.04), although other factors included FiO_2, prothrombin time, potassium, and pupil reflex in univariate analysis. In multiple logistic regression, there were significant factors of PaCO_2 (p = 0.028), O-PRISM (p = 0.039), and PIM2 (p = 0.004) for prognosis. For prediction of prognosis, O-PRISM (p = 0.019) was superior to PIM2 (p = 0.435) in intensive care children after HSCT. Conclusions: O-PRISM might be a predictable scoring system for children with ICU support, and the Glasgow coma scale and PaCO_2 were more reliable prognostic factors in the post-HSCT period.
Abstract
Background: Pediatric Index of Mortality 2 (PIM2) is a useful scoring system for the prediction of prognosis, and Oncological Pediatric Risk of Mortality (O-PRISM) for ICU support in children with HSCT. We investigated prognostic prediction and risk factors for survival through early detection of admission to ICU after HSCT. Methods: We reviewed retrospectively medical records of children cared for in ICU after HSCT between 2004 and 2010. Patients who died within 2 hours after admittance to ICU were excluded. We analyzed the worst parameters in ICU by a t-test, Cox-regression, multiple logistic regression and a receiver operating characteristics curve (ROC). Results: 54 children, with fifty-five disease events, were admitted to ICU after HSCT. Sixteen children were diagnosed with high-risk disease status and 8 with non-malignant diseases. Stem cells were sourced from 14 matched siblings, 22 unrelated donors and 19 cord bloods. The median duration in ICU was 8.5 days (0.5−110). The reasons for admission to ICU were 32 pulmonary, 14 neurologic, and 9 hemodynamic events. Six patients (11.1%) survived after intensive care. The factor indicating discharge with survival was mental status (p = 0.04), although other factors included FiO_2, prothrombin time, potassium, and pupil reflex in univariate analysis. In multiple logistic regression, there were significant factors of PaCO_2 (p = 0.028), O-PRISM (p = 0.039), and PIM2 (p = 0.004) for prognosis. For prediction of prognosis, O-PRISM (p = 0.019) was superior to PIM2 (p = 0.435) in intensive care children after HSCT. Conclusions: O-PRISM might be a predictable scoring system for children with ICU support, and the Glasgow coma scale and PaCO_2 were more reliable prognostic factors in the post-HSCT period.
참고문헌 (25)
- Savaşan S, "Current issues in pediatric stem cell transplantation", Clin Lab Med, 25, pp.519~540 (2005)
- Jackson SR, "Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors", Bone Marrow Transplant, 21, pp.697~704 (1998)
- Paz HL, "Outcome of patients requiring medical ICU admission following bone marrow transplantation", Chest, 104, pp.527~531 (1993)
- Pène F, "Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports", J Clin Oncol, 24, pp.643~649 (2006)
- van Gestel JP, "Intensive care unit mortality trends in children after hematopoietic stem cell transplantation: a meta-regression analysis", Crit Care Med, 36, pp.2898~2904 (2008)
- Pollack MM, "PRISM III: an updated Pediatric Risk of Mortality score", Crit Care Med, 24, pp.743~752 (1996)
- Pollack MM, "Pediatric risk of mortality (PRISM) score", Crit Care Med, 16, pp.1110~1116 (1988)
- Slater A, "The suitability of the Pediatric Index of Mortality (PIM), PIM2, the Pediatric Risk of Mortality (PRISM), and PRISM III for monitoring the quality of pediatric intensive care in Australia and New Zealand", Pediatr Crit Care Med, 5, pp.447~454 (2004)
- Slater A, "Paediatric Index of Mortality (PIM) Study Group: PIM2: a revised version of the Paediatric Index of Mortality", Intensive Care Med, 29, pp.278~285 (2003)
- 황희승, "단일 병원에서 소아 중환자의 예후인자 예측을 위한 PIM2 (pediatric index of mortality 2)와 PRIMS III (pediatric risk of mortality)의 유효성 평가 - 후향적 조사", Korean Journal of Pediatrics, 51(11), pp.1158~1164 (2008), 대한소아과학회
- Hayes C, "The outcome of children requiring admission to an intensive care unit following bone marrow transplantation", Br J Haematol, 102, pp.666~670 (1998)
- Schneider DT, "Introduction of the oncological pediatric risk of mortality score (O-PRISM) for ICU support following stem cell transplantation in children", Bone Marrow Transplant, 25, pp.1079~1086 (2000)
- Afessa B, "Critical care of the hematopoietic stem cell transplant recipient", Crit Care Clin, 26, pp.133~150 (2010)
- Cheuk DK, "Prognostic factors in children requiring admission to an intensive care unit after hematopoietic stem cell transplant", Hematol Oncol, 22, pp.1~9 (2004)
- Matulis M, "Immune reconstitution after hematopoietic stem-cell transplantation and its influence on respiratory infections", Semin Respir Infect, 17, pp.130~139 (2002)
- Hayes C, "The outcome of children requiring admission to an intensive care unit following bone marrow transplantation", Br J Haematol, 102, pp.666~670 (1998)
- Bratton SL, "Lower hospital mortality and complications after pediatric hematopoietic stem cell transplantation", Crit Care Med, 36, pp.923~927 (2008)
- Huaringa AJ, "Outcome of bone marrow transplantation patients requiring mechanical ventilation", Crit Care Med, 28, pp.1014~1017 (2000)
- Afessa B, "Intensive care unit support and Acute Physiology and Chronic Health Evaluation III performance in hematopoietic stem cell transplant recipients", Crit Care Med, 31, pp.1715~1721 (2003)
- Haire WD, "Multiple organ dysfunction syndrome in hematopoietic stem cell transplantation", Crit Care Med, 30(5), pp.S257~262 (2002)
- Warwick AB, "Outcomes following mechanical ventilation in children undergoing bone marrow transplantation", Bone Marrow Transplant, 22, pp.87~94 (1998)
- Kache S, "Changing outcomes for children requiring intensive care following hematopoietic stem cell transplantation", Pediatr Transplant, 10, pp.299~303 (2006)
- Fagon JY, "Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and", or infection: the ODIN model, 1993, pp.19, 137~144
- Lamia B, "Changes in severity and organ failure scores as prognostic factors in onco-hematological malignancy patients admitted to the ICU", Intensive Care Med, 32, pp.1560~1568 (2006)
- Schneider DT, "Serial evaluation of the oncological pediatric risk of mortality (O-PRISM) score following allogeneic bone marrow transplantation in children", Bone Marrow Transplant, 29, pp.383~389 (2002)